Grantham, Mayo, Van Otterloo & Co (GMO)’s Xylem XYL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-41,047	Closed	-$3.74M	–	593
2023 Q3	$3.74M	Buy	41,047 +36,543	+811%	+$3.77M	0.02%	341
2023 Q2	$507K	Buy	+4,504	New	+$476K	﹤0.01%	557
2018 Q1	–	Sell	-3,500	Closed	-$239K	–	636
2017 Q4	$239K	Sell	3,500 -1,860	-35%	-$123K	﹤0.01%	541
2017 Q3	$336K	Sell	5,360 -7,100	-57%	-$424K	﹤0.01%	455
2017 Q2	$691K	Sell	12,460 -200	-2%	-$10.4K	﹤0.01%	392
2017 Q1	$636K	Sell	12,660 -19,940	-61%	-$972K	﹤0.01%	387
2016 Q4	$1.61M	Buy	+32,600	New	+$1.65M	0.01%	332

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s XYL Position: Q4 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Xylem (XYL) in Q4 2023, closing a stake of 41,047 shares — an estimated $3.74M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in XYL in Q4 2016 and held it in 7 quarters. The position peaked at $3.74M in Q3 2023. 922 funds tracked by Wall St. Rank hold XYL as of Q4 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Xylem position as of Q4 2023 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 41,047 Xylem shares in Q4 2023, an estimated $3.74M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Xylem in Q4 2016 and held it in 7 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Xylem position peaked at $3.74M in Q3 2023.
922 funds tracked by Wall St. Rank held Xylem as of Q4 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2023, filed 13 Feb 2024.